Abstract
The advancement of novel materials and manufacturing technologies offer opportunities to explore new applications in the space of medical devices. Among these advances, biobased polymers with antimicrobial activity can be used to develop prototypes by additive manufacturing, thereby enabling further exploration with benefits to time and cost. The objective of this research was to assess the effectiveness of polylactic acid (PLA) biopolymer embedded with a copper-based composite (active PLA) to reduce and prevent bacterial growth of microorganisms of concern that may lead to the formation of biofilms. The research was carried out by manufacturing coupons of active PLA using additive manufacturing to test the growth or lack thereof of microorganisms known to form biofilms in medical devices, particularly those with narrow lumens. Testing showed 99.99% antimicrobial effectiveness in reducing Pseudomonas aeruginosa (9027), Escherichia coli (8739), and Klebsiella pneumoniae (4352) growth after 24 hours of exposure. The results confirm the effectiveness of active PLA in preventing microbial growth, which opens the possibility of its use for other medical device applications. Further testing is required, particularly regarding toxicological aspects and potential concerns about the size of copper particles.